Logan Energy Corp. (TSXV: LGN) ("Logan" or the "Company") is pleased to announce that, as a result of excess demand, it has ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the European Commission has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results